Podcast Episodes
Back to Search
Why the NFLX Selloff Is a $25 Billion Mistake
Netflix collects $2.8B cash to trigger $25B buyback — NFLX stock analysis: buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... …
6 days, 13 hours ago
The CFO Panic Driving ADBE to a 7-Year Low of $204
ADBE hits 8.5x forward earnings — 7-year low valuation buy or sell stock analysis
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FR…
6 days, 13 hours ago
BOF: 100% Growth Meets Going Concern Warning
BOF stock analysis: BranchOut Food risks going concern despite 113% growth — buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD...…
6 days, 14 hours ago
LFTO Trades at a 50% Valuation Discount to AppLovin
LFTO stock analysis: 50% valuation discount signals massive upside — buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FRE…
6 days, 14 hours ago
EVC: The 204% Ad-Tech Surge Wall Street Is Ignoring
Entravision (EVC) stock analysis: ad-tech surge triggers 114% growth — buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... for …
6 days, 14 hours ago
Atlassian Stock: The 87% Gross Margin Disconnect
Atlassian (TEAM) drops to 14x forward earnings — buy or sell stock analysis
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Ch…
6 days, 15 hours ago
Netflix Is Down 40% While Free Cash Flow Surges
Netflix (NFLX) crashes 40% to 26.5x valuation — buy or sell streaming stock analysis
👉 Want this level of research on ANY COMPANY IN THE WORLD... for…
6 days, 17 hours ago
Why Insiders Are Buying EQPT Despite $4 Billion Debt
EQPT grows revenues 38% YoY at a 5.15x valuation — stock analysis: buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…
6 days, 17 hours ago
ACS.MC: The €19B AI Shift the Market Underestimates
ACS.MC targets 15x data center growth with €100B backlog — valuation stock analysis deep dive
👉 Want this level of research on ANY COMPANY IN THE WOR…
6 days, 18 hours ago
Why COAG Stock Is the Ultimate Phase 3 Gamble
COAG stock analysis: Hemab targets 87% bleed reduction — biotech buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? C…
6 days, 18 hours ago